Aspartate 102 in the Heme Domain of Soluble Guanylyl Cyclase Has a Key Role in NO Activation

被引:14
作者
Baskaran, Padmamalini [2 ]
Heckler, Erin J. [2 ]
van den Akker, Focco [1 ]
Beuve, Annie [1 ]
机构
[1] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44120 USA
[2] UMDNJ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA
基金
美国国家卫生研究院;
关键词
NITRIC-OXIDE; BINDING-SITE; MECHANISM; INSIGHTS; MOIETY; SENSOR;
D O I
10.1021/bi2004087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Nitric oxide (NO) is involved in the physiology and pathophysiology of the cardiovascular and neuronal systems via activation of soluble guanylyl cyclase (sGC), a heme-containing heterodimer. Recent structural studies have allowed a better understanding of the residues that dictate the affinity and binding of NO to the heme and the resulting breakage of the bond between the heme iron and histidine 105 (H105) of the beta subunit of sGC. Still, it is unknown how the breakage of the iron His bond translates into NO-dependent increased catalysis. Structural studies on homologous H-NOX domains in various states pointed to a role for movement of the H105 containing alpha F helix. Our modeling of the heme-binding domain highlighted conserved residues in the vicinity of H105 that could potentially regulate the extent to which the aF helix shifts and/or propagate the activation signal once the covalent bond with H105 has been broken. These include a direct interaction of alpha F helix residue aspartate 102 (D102) with the backbone nitrogen of F120. Mutational analysis of this region points to an essential role of the interactions in the vicinity of H105 for heme stability and identifies D102 as having a key role in NO activation following breakage of the iron-His bond.
引用
收藏
页码:4291 / 4297
页数:7
相关论文
共 25 条
[1]
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling [J].
Arnold, K ;
Bordoli, L ;
Kopp, J ;
Schwede, T .
BIOINFORMATICS, 2006, 22 (02) :195-201
[2]
Dynamical characterization of the heme NO oxygen binding (HNOX) domain. Insight into soluble guanylate cyclase allosteric transition [J].
Capece, Luciana ;
Estrin, Dario A. ;
Marti, Marcelo A. .
BIOCHEMISTRY, 2008, 47 (36) :9416-9427
[3]
Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase [J].
Chang, FJ ;
Lemme, S ;
Sun, Q ;
Sunahara, RK ;
Beuve, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :11513-11519
[4]
Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase [J].
Derbyshire, Emily R. ;
Marletta, Michael A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (49) :35741-35748
[5]
A structural basis for H-NOX signaling in Shewanella oneidensis by trapping a histidine kinase inhibitory conformation [J].
Erbil, W. Kaya ;
Price, Mark S. ;
Wemmer, David E. ;
Marletta, Michael A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (47) :19753-19760
[6]
A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase [J].
Fernhoff, Nathaniel B. ;
Derbyshire, Emily R. ;
Marletta, Michael A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (51) :21602-21607
[7]
Mechanism of YC-1-induced activation of soluble guanylyl cyclase [J].
Friebe, A ;
Koesling, D .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :123-127
[8]
Nitric oxide as a signaling molecule in the vascular system: An overview [J].
Ignarro, LJ ;
Cirino, G ;
Casini, A ;
Napoli, C .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (06) :879-886
[9]
ACTIVATION OF PURIFIED SOLUBLE GUANYLATE-CYCLASE BY PROTOPORPHYRIN-IX [J].
IGNARRO, LJ ;
WOOD, KS ;
WOLIN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (09) :2870-2873
[10]
Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: Structural implication for the YC-1 binding site? [J].
Lamothe, M ;
Chang, FJ ;
Balashova, N ;
Shirokov, R ;
Beuve, A .
BIOCHEMISTRY, 2004, 43 (11) :3039-3048